Capex / expansionNotableFiled on BSE ·

Lord’s Mark Industries completes Silvassa expansion, to export 200+ products to US

Lords Mark Industries · Commercial Services & Supplies

What the filing says

  • Asia’s first company to secure US FDA registration for over 200 surgical and hygiene products
  • Silvassa manufacturing expansion finished ahead of schedule, enabling international market readiness
  • Exports to the US start December 2026, with South America planned subject to regulatory approvals

Why it's rated notable: No capex or revenue amount is stated, so the level rests on US FDA registration for more than 200 products, a completed Silvassa capacity expansion, and US exports planned from December 2026.

Original filing

Silvassa Manufacturing Expansion Completed Ahead Of Schedule As The Company Prepares To Expand Its International Footprint Across The United States And South America

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Lords Mark Industries

Other capex / expansion filings this fortnight

All capex / expansion filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.